Developing Blood-Brain Barrier-Crossing AAV9 Variants with Reduced Sensitivity to Neutralizing Antibodies

被引：0
|
作者：
Pacouret, Simon [1 ]
Chan, Ken Y. [1 ]
Eid, Fatma Elzahraa [1 ]
Donahoe, William [1 ]
Brauer, Pamela [1 ]
Zhao, Binhui [1 ]
Huang, Qin [1 ]
Johnson, Jencilin [1 ]
Zheng, Qingxia [1 ]
Chen, Albert [1 ]
Barry, Andrew J. [1 ]
Keyes, Casey [1 ]
Chan, Yujia A. [1 ]
Deverman, Benjamin E. [1 ]
机构：
[1] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
106
引用
收藏
页码：57 / 57
页数：1
相关论文
共 50 条
  • [1] AAV9: a potential blood-brain barrier buster
    Manfredsson, Fredric P.
    Rising, Aaron C.
    Mandel, Ronald J.
    MOLECULAR THERAPY, 2009, 17 (03) : 403 - 405
  • [2] Blood-brain barrier-crossing dendrimers for glioma theranostics
    Wang, Jinxia
    Wang, Zhiqiang
    Zhang, Guixiang
    Rodrigues, Joao
    Tomas, Helena
    Shi, Xiangyang
    Shen, Mingwu
    BIOMATERIALS SCIENCE, 2024, 12 (06) : 1346 - 1356
  • [3] Customized Blood-Brain Barrier Shuttle Peptide to Increase AAV9 Vector Crossing the BBB and Enhance Transduction in the Brain
    Zhang, Xintao
    Chai, Zheng
    Dobbins, Amanda Lee
    Samulski, Richard Jude
    Li, Chengwen
    MOLECULAR THERAPY, 2019, 27 (04) : 186 - 186
  • [4] Customized blood-brain barrier shuttle peptide to increase AAV9 vector crossing the BBB and augment transduction in the brain
    Zhang, Xintao
    Chai, Zheng
    Dobbins, Amanda Lee
    Itano, Michelle S.
    Askew, Charles
    Miao, Zhe
    Niu, Hongqian
    Samulski, R. Jude
    Li, Chengwen
    BIOMATERIALS, 2022, 281
  • [5] Crossing the blood-brain barrier with AAV vectors
    Liu, Dan
    Zhu, Mingyang
    Zhang, Yuqian
    Diao, Yong
    METABOLIC BRAIN DISEASE, 2021, 36 (01) : 45 - 52
  • [6] Crossing the blood-brain barrier with AAV vectors
    Dan Liu
    Mingyang Zhu
    Yuqian Zhang
    Yong Diao
    Metabolic Brain Disease, 2021, 36 : 45 - 52
  • [7] Natural AAV2 Variants Demonstrate Stronger Neurotropism, Penetrance of the Blood-Brain Barrier, and Differential Transduction of Brain Regions Compared to AAV9
    Liu, Sophia
    Leland, Thomas
    Muhuri, Manish
    Lotun, Anoushka
    Xu, Meiyu
    Xu, Guangchao
    Luo, Li
    Qin, Wanru
    He, Ran
    Su, Qin
    Xie, Jun
    Wei, Yu-Quan
    Tai, Phillip W. L.
    Gao, Guangping
    MOLECULAR THERAPY, 2023, 31 (04) : 592 - 592
  • [8] A novel platform for engineering blood-brain barrier-crossing bispecific biologics
    Farrington, Graham K.
    Caram-Salas, Nadia
    Haqqani, Arsalan S.
    Brunette, Eric
    Eldredge, John
    Pepinsky, Blake
    Antognetti, Giovanna
    Baumann, Ewa
    Ding, Wen
    Garber, Ellen
    Jiang, Susan
    Delaney, Christie
    Boileau, Eve
    Sisk, William P.
    Stanimirovic, Danica B.
    FASEB JOURNAL, 2014, 28 (11): : 4764 - 4778
  • [9] Advances in blood-brain barrier-crossing nanomedicine for anti-glioma
    Liu, Dongdong
    Dai, Xingliang
    Tao, Zhenchao
    Zhou, Hu
    Hong, Wenqing
    Qian, Haisheng
    Cheng, Hongwei
    Wang, Xianwen
    CANCER NANOTECHNOLOGY, 2023, 14 (01)
  • [10] The neonatal blood-brain barrier is functionally effective, and immaturity does not explain differential targeting of AAV9
    Saunders, Norman R.
    Ek, C. Joakim
    Dziegielewska, Katarzyna M.
    NATURE BIOTECHNOLOGY, 2009, 27 (09) : 804 - 804
12345